Cytogenetic and molecular genetic abnormalities in systemic mastocytosis

Acta Haematologica

Volumn 107, Issue 2, 2002, Pages 123-128

  Gupta, Rajeev ^a,b   Bain, Barbara J ^a   Knight, Caroline L ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

c KIT; Cytogenetics; Mastocytosis; Molecular genetics; Urticaria pigmentosa

Indexed keywords

ASPARTIC ACID; STEM CELL FACTOR RECEPTOR; VALINE;

CYTOGENETICS; GENE MUTATION; GENETIC CODE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MAST CELL; MOLECULAR GENETICS; ONCOGENE C KIT; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SYSTEMIC MASTOCYTOSIS; URTICARIA PIGMENTOSA;

ADULT; CHILD; CHROMOSOME ABERRATIONS; CLONE CELLS; CYTOGENETIC ANALYSIS; HEMATOLOGIC NEOPLASMS; HUMANS; MASTOCYTOSIS; MUTATION; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 0036204668     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046642     Document Type: Review

References (41)

1. Trisomies 9 and 8 detected by fluorescence in situ hybridization in patients with systemic mastocytosis
2. Cytogenetic studies in patients with mastocytosis
3. Cytogenetic studies and in vitro colony growth in patients with mastocytosis
4. Significance of systemic mast cell disease with associated haematologic diagnosis
5. A case of malignant mastocytosis with near-haploid, near-diploid, and polyploid cells in the bone marrow
6. Philadelphia chromosome-negative acute hemopoietic malignancy: Ultrastructural, cytochemical and immunocytochemical evidence of mast cell and basophil differentiation
7. A near-haploid marrow in systemic mast cell disease: Is it characteristic of the disease or an incidental finding?
8. In vivo differentiation of mast cells from AML M2 blasts carrying a novel activating ligand-independent c-KIT mutation
9. Concurrent acute myeloid leukemia and systemic mastocytosis
10. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: Evidence for expression of CD2, CD117/Kit, and bcl-x(L)
11. Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia
12. Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice -evidence for an impaired c-kit kinase in mutant mice
13. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand
14. Systemic mastocytosis and other mast cell neoplasms
15. Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: Relationships to disease severity and bone marrow pathology
16. Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells and myelomonocytic cells in patients with mastocytosis
17. Lineage involvement of stem cells bearing the philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization
18. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis
19. Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase
20. Activating mutation in the catalytic domain of c-kit elicits hematopoietic transformation by receptor self-association not at the ligand-induced dimerization site
21. Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1
22. PI3 kinase mediates transformation of hematopoietic cells by the V816 c-kit mutant
23. Effects of mutan c-kit in early myeloid cells
24. Interleukin-4 inhibits the expression of Kit and tryptase during stem cell factor-dependent development of human mast cells from fetal liver cells
25. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor
26. Association of the Q576R polymorphism in the interleukin-4 receptor alpha chain with indolent mastocytosis limited to the skin
27. Mast cell disease followed by leukemia with cloncal evolution
28. Translocation [X;8][q2?6;q21.3] in a case of systemic mastocytosis
29. Mast cell leukemia: Report of a case and review of the literature
30. Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: A possible explanation for divergent clinical behavior
31. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder
32. c-kit mutation in a population of patients with mastocytosis
33. Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis
34. Analysis of c-kit exon 11 and exon 17 of urticaria pigmentosa that occurred in monozygotic twin sisters
35. Mast cell disease associated with acute myeloid leukemia: Detection of a new c-kit mutation Asp816His
36. Multilineage involvement and erythropoietin-'independent' erythroid progenitor cells in a patient with systemic mastocytosis
37. Systemic mastocytosis associated with acute myeloid leukaemia: Report of two cases and detection of the c-kit mutation Asp-816 to Val
38. Detection of c-kit mutation Asp816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia
39. c-kit mutations in core binding factor leukemias
40. A new c-kit mutation in a case of aggressive mast cell disease